Endocrinology

Latest News

Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials

September 6th 2024

Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.

Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose / image credit: ©New Africa/AdobeStock
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose

September 3rd 2024

PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose / image credit: ©New Africa/AdobeStock
PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose

August 29th 2024

T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association / Image credit: ©Jacob Lund/AdobeStock
T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association

August 29th 2024

New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment / Image credit: ©yuriygolub/AdobeStock
New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment

August 28th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.